Impact of extended [(177)Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?


Topal E., Kovan B., İribas A., Kuyumcu S., Basaran M., Malçok Demirtaş A., ...Daha Fazla

European journal of nuclear medicine and molecular imaging, 2025 (SCI-Expanded, Scopus) identifier